Trial Amendment Approval is a formal regulatory determination issued by a competent authority or ethics committee that authorizes modifications to an already approved clinical trial protocol, distinguishing it from initial trial authorization by specifically addressing and validating changes to study design, methodology, or conduct after the trial has commenced.
2
Publications
160
Citations
19
Authors
22
Institutions
Publications per year
2017–2026
2
Parents
Publications
2
Athena Philis‐Tsimikas, Irene Stratton, Lone Troelsen et al. · Journal of Diabetes Science and Technology · 2019 · 22 citations · Full text
1–2 of 2
Authors
19
- NGNicholas G. Gottardo
Princess Margaret Hospital for Children, Australia
1 publications · 138 citations
1
h-index
- BA
1
h-index
- AG
1
h-index
- AO
1
h-index
- DCDaniel C. Bowers
The University of Texas Southwestern Medical Center, United States
1 publications · 138 citations
1
h-index
1–5 of 19
Institutions
22
The University of Western Australia
Perth, Australia
1 h-index
1 publications
138 citations
Princess Margaret Hospital for Children
Perth, Australia
1 h-index
1 publications
138 citations
Scripps Whittier Diabetes Institute
San Diego, United States
1 h-index
1 publications
22 citations
Center for Children
La Plata, United States
1 h-index
1 publications
138 citations
St. Michael's Hospital
Toronto, Canada
1 h-index
1 publications
22 citations
Campbell Clinic
Memphis, United States
1 h-index
1 publications
138 citations
University of Toronto
Toronto, Canada
1 h-index
1 publications
22 citations
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Boston, United States
1 h-index
1 publications
138 citations
1–8 of 22
Venues
- Journal of Diabetes Science and Technology
DST · 1 publications · 22 citations
1
h-index
- Oncotarget
1 publications · 138 citations
1
h-index
1–2